PRPH In general, I like the CEO, but on this call I found him a little tough to understand on the covid testing and profitability. HRSA funding not approved yet and may not come, that's roughly half of revenue. Second and third quarter likely to be lower revenues, but did you get the impression they'll still be profitable for q2 and q3? At some points he seemed to say yes, at other points it felt like he was saying profitable for the year, but maybe not next two q's?
News 
Market Data 
Discover 
